跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,428 条关于
“VTX-PID”
全部
8,428
临床试验
6,309
药物
1,454
机构
51
资讯
614
3天前
Lexeo to Acquire Mantle Therapeutics for Up to $21.3M, Adding Four Frataxin-Targeting FA Programs
去年
VectorY Therapeutics Unveils Promising Preclinical Data for Novel ALS Treatment Targeting Oxidized Phospholipids
去年
VectorY Therapeutics Appoints Jim Scibetta as CEO, Advances ALS Program
9个月前
FDA Clears First-in-Class Vectorized Antibody Trial for ALS Targeting TDP-43 Pathology
去年
VectorY Therapeutics Secures $1.2B+ Deal for Shape's Brain-Penetrant AAV Capsid Technology
去年
Pharming Group Initiates Phase II Trial of Leniolisib for Primary Immunodeficiencies
去年
Quince Therapeutics Strengthens Scientific Advisory Board with Leading Immunologist Ahead of Phase 3 Results
去年
Takeda's HYQVIA Approved in Japan for Agammaglobulinemia and Hypogammaglobulinemia
去年
NLRP3 Inhibitors Show Promise Across Autoimmune, Neurodegenerative, and Metabolic Diseases
7个月前
Pharming Advances Rare Disease Pipeline with Napazimone for Mitochondrial Disease and Leniolisib Expansion
第 1 页,共 62 页
上一页
下一页